Thirty-Day Outcomes of Direct Carotid Artery Stenting With Cerebral Protection in High-Risk Patients
Josef Veselka(Universitat Autònoma de Barcelona), Radka Duchoňová(University Hospital in Motol), Petra Zimolová(University Hospital in Motol), Peter Blaško, Martin Malý(Charles University), Jiří Fiedler(Charles University), David Zemánek, Daniela Černá(University Hospital in Motol), Petr Hájek(University Hospital in Motol)
Cited by 25
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Long‐term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS
|Catheterization and Cardiovascular Interventions|2009|190
Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population
|European Heart Journal|2014|106
A FTO variant and risk of acute coronary syndrome
|Clinica Chimica Acta|2010|65